255 related articles for article (PubMed ID: 12730079)
1. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
Prabhakaran P; Ware LB; White KE; Cross MT; Matthay MA; Olman MA
Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L20-8. PubMed ID: 12730079
[TBL] [Abstract][Full Text] [Related]
2. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.
Sapru A; Curley MA; Brady S; Matthay MA; Flori H
Intensive Care Med; 2010 Jan; 36(1):157-63. PubMed ID: 19855955
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
5. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.
Kropski JA; Fremont RD; Calfee CS; Ware LB
Chest; 2009 Jun; 135(6):1440-1447. PubMed ID: 19188556
[TBL] [Abstract][Full Text] [Related]
6. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
[TBL] [Abstract][Full Text] [Related]
7. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
8. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma.
Pavey SJ; Hawson GA; Marsh NA
Blood Coagul Fibrinolysis; 2001 Jan; 12(1):51-8. PubMed ID: 11229827
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance.
Verghese GM; McCormick-Shannon K; Mason RJ; Matthay MA
Am J Respir Crit Care Med; 1998 Aug; 158(2):386-94. PubMed ID: 9700111
[TBL] [Abstract][Full Text] [Related]
10. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
13. Enhanced fibrinolysis protects against lung ischemia-reperfusion injury.
Lau CL; Zhao Y; Kim J; Kron IL; Sharma A; Yang Z; Laubach VE; Linden J; Ailawadi G; Pinsky DJ
J Thorac Cardiovasc Surg; 2009 May; 137(5):1241-8. PubMed ID: 19379998
[TBL] [Abstract][Full Text] [Related]
14. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.
Tsangaris I; Tsantes A; Bonovas S; Lignos M; Kopterides P; Gialeraki A; Rapti E; Orfanos S; Dimopoulou I; Travlou A; Armaganidis A
Thromb Res; 2009 Apr; 123(6):832-6. PubMed ID: 18804848
[TBL] [Abstract][Full Text] [Related]
15. The abnormalities of coagulation and fibrinolysis in acute lung injury caused by gas explosion.
Tian LQ; Guo ZH; Meng WZ; Li L; Zhang Y; Yin XH; Lai F; Li YY; Feng LL; Shen FF; Sun ZZ; Yao SQ; Wu WD; Weng XG; Ren WJ
Kaohsiung J Med Sci; 2020 Nov; 36(11):929-936. PubMed ID: 32643870
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.
Agrawal A; Zhuo H; Brady S; Levitt J; Steingrub J; Siegel MD; Soto G; Peterson MW; Chesnutt MS; Matthay MA; Liu KD
Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(8):L634-9. PubMed ID: 22865551
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
18. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
19. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
